differentiated thyroid cancer
Conditions
Interventions
experiment group:SNA001 injection
controll group:THW
Sponsors
Zhongshan Hospital of Fudan University
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18 to 70 years, male and female, when signing informed consent form; 2. Willingness to participate clinical study, and sign ICF, who possessed behavioral abilitity; 3. ECOG score 0-1 at screening phase(see Appendix 1); 4. Basal heart rate 55-110 time/min at screening phase(boundary value included); 5. Blood pressure =4 weeks) before screening; 8. TSH treatment >=4 weeks after total or near total thyroidectomy; 9. Low iodine diet for two weeks before screening phase; 10. According to AJCC Seventh Version, T1-3, N0-1, or NxM0(see Appendix 2); 11. TSH< 5mU/L detected in study sites at screening phase;
Exclusion criteria
Exclusion criteria: 1. Estimated survival time 10 ng/mL without disturbance of TgAb; 8. Patients combined with thyroiditis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| remnant ablative rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum Tg and TgAb level;Serum TSH level;131I dosage; | — |
Countries
China
Contacts
Public ContactLiu Bin
West China Hospital, Sichuan University
Outcome results
None listed